Shineco inc

MarketScreener is also available in this country: United States. Add to a list Add to a list. To use this feature you shineco inc be a member. Inactive Instrument Shineco, Inc.

Forgot password? Don't have an account? Sign Up! Already have an account? A Leap Forward in Laundry: Tide launches a revolutionary new tile

Shineco inc

The reverse stock split is expected to become effective on February 16, the "Effective Date" , and the shares are expected to begin trading on the split-adjusted basis on the Nasdaq Stock Exchange "Nasdaq" under the Company's existing trading symbol "SISI" at the market open on February 16, On the Effective Date, every 10 issued and outstanding shares of the Company's Common Stock will be converted automatically into one share of the Company's Common Stock without any change in the par value per share. Immediately after the reverse stock split, each stockholder's percentage ownership interest in the Company and proportional voting power will remain unchanged, except for minor changes and adjustments that will result from the rounding up of any fractional shares to the next whole number of shares. The rights and privileges of the holders of shares of Common Stock will be substantially unaffected by the reverse stock split. Transhare Corporation is acting as transfer and exchange agent for the reverse stock split. Registered shareholders who hold shares of Common Stock are not required to take any action to receive post-reverse stock split shares. Stockholders who hold their shares in brokerage accounts or in "street name" will have their positions automatically adjusted to reflect the reverse stock split, subject to each broker's particular processes, and will not be required to take any action in connection with the reverse stock split. Shineco Inc. Shineco, operating through subsidiaries, has researched and developed 33 vitro diagnostic reagents and related medical devices to date, and the Company also produces and sells healthy and nutritious foods. For more information about Shineco, please visit www. This news release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of , as amended, and Section 21E of the Securities Exchange Act of , as amended. These forward-looking statements can be identified by terminology such as "may", "will", "should", "could", "intend", "expect", "plan", "budget", "forecast", "anticipate", "believe", "estimate", "predict", "potential", "continue", "evaluating" or similar words. Forward-looking statements should not be relied upon because they are neither historical facts nor assurances of future performance.

Immediately after the shineco inc stock split, each stockholder's percentage ownership interest in the Company and proportional voting power will remain unchanged, shineco inc, except for minor changes and adjustments that will result daymınt the rounding up of any fractional shares to the next whole number of shares. Changzhou Biowin Pharmaceutical Co. Audit Committee Charter IV.

Code of Business Conduct and Ethics. Corporate Governance Guidelines. Audit Committee Charter. Compensation Committee Charter. Nominating and Corporate Governance Committee Charter.

Code of Business Conduct and Ethics. Corporate Governance Guidelines. Audit Committee Charter. Compensation Committee Charter. Nominating and Corporate Governance Committee Charter.

Shineco inc

The COVID and Monkeypox detection reagents are two examples of POCT, which provide quick, simple, efficient, and affordable detection methods and may become widely adopted in the fast-growing market. Marvin Liu, the founder and Chairman of CBP, received his medical degree from the Peking Union Medical College, the most prestigious medical college in China, and had his post-doctoral training at Dartmouth College in the United States and is a national leading expert in the biomedical industry of China. Under his leadership, CBP has developed 16 categories of 55 products in the field of rapid diagnostics within just a few years, and established an ISO certified manufacture facility and quality control system for related products, as well as the following POCT related technology platforms: colloidal gold immunoassay, fluorescence immunoassay, and loop-mediated isothermal amplification LAMP nucleic acid detection. Advanced technological innovation is the CBP's business strategy and development pursuit. So far, CBP has 38 issued patents and pending patents, and among these patent technologies, 6 home tests, 5 fluorescent tests, and 1 medical device have been developed. All of the products with huge market potential worldwide are designed for the use of clinical diagnosis and rapid screening of the most common diseases. Recently, many countries promoted at-home self-test products due to the escalating demand for COVID testing. The usage demand of POCT products has changed and shown a trend toward self-testing, and we expect the market volume will be significantly higher than expected. Personal healthcare has also been increasingly important in China to meet the increasing demands of the health-conscious and aging population.

Gray daniels ford

Erweiterte Suche. Financial Analyst. Open 1. All content on FT. A confirmation email has been sent to your email address. Financial Times Close. Rudnick david. Indizes Indexliste. In the case of Shineco Inc. However, it can lead to a perceived increase in the stock's value, potentially attracting institutional investors who might have restrictions against purchasing stocks below a certain price. Erneuerbare Energien. Forgot password?

Shineco, Inc. The COVID and Monkeypox detection reagents are two examples of POCT, which provide quick, simple, efficient, and affordable detection methods and may become widely adopted in the fast-growing market.

Additionally, the reverse split does not impact the rights and privileges of the current shareholders, which is a positive sign for investor relations. A confirmation email has been sent to your email address. Sonstige Technologie. Shineco encourages you to review other factors that may affect its future results in its filings with the Securities and Exchange Commission. Compensation Committee Charter V. Open 1. Shineco encourages you to review other factors that may affect its future results in its filings with the Securities and Exchange Commission. Top Premarket Gainers. Examples of forward-looking statements include, among others, statements we make regarding the innovativeness and market position of our products and services, our competitive strengths, and our expectation that the Cardiac 5-minute Test will be one of the leading products in this field to meet the demand of obtaining the test result shortly upon arrival. Compensation Committee Charter. The Other Agricultural Products segment plants, processes and distributes green and organic agricultural produce as well as grows and cultivates yew trees. Examples of forward-looking statements include, among others, statements we make regarding the innovativeness and market position of our products and services, our competitive strengths, and our expectation that the Cardiac 5-minute Test will be one of the leading products in this field to meet the demand of obtaining the test result shortly upon arrival. Shineco, Inc. You are cautioned not to rely on any forward-looking statements. Shineco, Inc.